Lazard Asset Management Portfolio holdings
AUM
$72.7B
1-Year Return
14.89%
This Quarter Return
+11.1%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$79B
AUM Growth
+$5.52B
(+7.5%)
Cap. Flow
-$7.71B
Cap. Flow
% of AUM
-9.75%
Top 10 Holdings %
Top 10 Hldgs %
24.46%
Holding
2,612
New
284
Increased
737
Reduced
832
Closed
260
Top Buys
| 1 |
Chubb
CB
|
+$574M |
| 2 |
American Electric Power
AEP
|
+$284M |
| 3 |
Ulta Beauty
ULTA
|
+$187M |
| 4 |
CVS Health
CVS
|
+$177M |
| 5 |
McDonald's
MCD
|
+$151M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$422M |
| 2 |
Johnson & Johnson
JNJ
|
+$213M |
| 3 |
Aon
AON
|
+$192M |
| 4 |
Norfolk Southern
NSC
|
+$183M |
| 5 |
CyberArk
CYBR
|
+$168M |
Sector Composition
| 1 | Technology | 20.99% |
| 2 | Financials | 14.11% |
| 3 | Healthcare | 13.38% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Enpro
NPO
$4.77B
| $77K | ﹤0.01% |
+494
| New | +$77K |
|
1577
Universal Corp
UVV
$1.4B
| $77K | ﹤0.01% |
1,152
+228
| +25% | +$15.2K |
|
1578
Aurinia Pharmaceuticals
AUPH
$1.68B
| $76K | ﹤0.01% |
8,641
-46,787
| -84% | -$412K |
|
1579
Cabaletta Bio
CABA
$166M
| $76K | ﹤0.01% |
3,403
+118
| +4% | +$2.64K |
|
1580
Herbalife
HLF
$964M
| $76K | ﹤0.01% |
5,010
+274
| +6% | +$4.16K |
|
1581
Manitowoc
MTW
$363M
| $76K | ﹤0.01% |
4,567
-5,426
| -54% | -$90.3K |
|
1582
Sprout Social
SPT
$848M
| $76K | ﹤0.01% |
1,250
+80
| +7% | +$4.86K |
|
|
MRTX
1583
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $76K | ﹤0.01% |
+1,294
| New | +$76K |
|
1584
Archrock
AROC
$4.36B
| $75K | ﹤0.01% |
+4,900
| New | +$75K |
|
1585
SPDR Bloomberg High Yield Bond ETF
JNK
$8.12B
| – | – |
0
| – | -$72K |
|
1586
Opendoor
OPEN
$7.74B
| $75K | ﹤0.01% |
16,826
+62
| +0.4% | +$276 |
|
|
AUTL
1587
Autolus Therapeutics
AUTL
$381M
| $74K | ﹤0.01% |
11,551
+531
| +5% | +$3.4K |
|
1588
Golar LNG
GLNG
$4.16B
| $74K | ﹤0.01% |
+3,249
| New | +$74K |
|
1589
Integral Ad Science
IAS
$1.44B
| $74K | ﹤0.01% |
5,161
-9,480
| -65% | -$136K |
|
1590
Intapp
INTA
$3.73B
| $74K | ﹤0.01% |
1,970
+64
| +3% | +$2.4K |
|
1591
Liberty Latin America Class A
LILA
$1.53B
| $74K | ﹤0.01% |
+10,371
| New | +$74K |
|
1592
Mirum Pharmaceuticals
MIRM
$3.82B
| $74K | ﹤0.01% |
2,516
+74
| +3% | +$2.18K |
|
1593
Owens & Minor
OMI
$423M
| $74K | ﹤0.01% |
3,875
-217
| -5% | -$4.14K |
|
1594
Portillo's
PTLO
$442M
| $74K | ﹤0.01% |
4,714
-346
| -7% | -$5.43K |
|
1595
The RMR Group
RMR
$289M
| $74K | ﹤0.01% |
2,626
+20
| +0.8% | +$564 |
|
1596
TriNet
TNET
$3.48B
| $74K | ﹤0.01% |
625
-284
| -31% | -$33.6K |
|
|
PGTI
1597
DELISTED
PGT, Inc.
PGTI
| $74K | ﹤0.01% |
+1,822
| New | +$74K |
|
1598
CoreCivic
CXW
$2.29B
| $73K | ﹤0.01% |
+5,043
| New | +$73K |
|
1599
First Solar
FSLR
$21.8B
| $73K | ﹤0.01% |
429
-37,913
| -99% | -$6.45M |
|
1600
Harmony Biosciences
HRMY
$1.92B
| $73K | ﹤0.01% |
2,291
+109
| +5% | +$3.47K |
|